Skip to content

The value of MRI Radiogenomics in Predicting Phenotype and Revealing Mechanism of Axial Spondyloarthritis

The value of MRI Radiogenomics in Predicting Phenotype and Revealing Mechanism of Axial Spondyloarthritis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073649
Enrollment
Unknown
Registered
2023-07-18
Start date
2022-07-25
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Axial Spondyloarthritis

Interventions

axSpA:None
non-axSpA:None
RA:None
Active axSpA:None
Inactive axSpA:None

Sponsors

First Affiliated Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. axSpA and non axSpA patients: (i)Low back pain patients axSpA was clinically suspected and rheumatologist confirm the non-axSpA or axSpA diagnosis using ASAS classification criteria; (ii) performance of 3.0T sacroiliac joint MRI examination; (iii) obtained from the same MRI machine; (iv) availability of complete MRI datasets and clinical information; (v) Perform laboratory analysis through routine blood tests within one week prior to MRI examination. 2. Patients with active and inactive axSpA: (1) Active and inactive axSpA were classified according to the VAS score of back pain =4cm and the BASDAI disease Activity Index score =4 (0-10); (2) - (5) Same as axSpA. 3. RA: (1) Rheumatologists use the 2010 ACR/EULAR RA classification criteria to confirm the diagnosis; (2) - (5) Same as axSpA.

Exclusion criteria

Exclusion criteria: axSpA and non-AXSPA patients, active axSpA and inactive axSpA patients, RA patients: (i) Age <18 years; (ii) have used biological agents within one year; (iii) MRI cannot be perfected.

Design outcomes

Primary

MeasureTime frame
Sacroiliac joint MRI;transcriptome;Radiomics;

Secondary

MeasureTime frame
Age;Gender;Disease duration;Occupation;Smoking status;Body Mass Index;Family history;Morning stiffness;Hip pain;Peripheral arthritis;Uveitis;Inflammatory bowel disease;Psoriasis;Achilles tendinitis;Dactylitis;ESR;CRP;HLA-B27;Cytokines 12 items;ASDAS-CRP?ASDAS-ESR;BASDAI;BASFI; RT-qPCR;

Countries

China

Contacts

Public ContactLusi Ye

First Affiliated Hospital, Wenzhou Medical University

yelusi@hotmail.com+86 137 5789 4089

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026